Portola Pharmaceuticals: 2Q Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Portola Pharmaceuticals Inc. (PTLA) on Thursday reported a loss of $106.2 million in its second quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.61.
The biopharmaceutical company posted revenue of $4 million in the period.
Portola Pharmaceuticals shares have decreased 23 percent since the beginning of the year. The stock has decreased 37 percent in the last 12 months.